UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Perioperative Therapy for Resectable Pancreatic Cancer

Phase 2

Completed

Conditions: Adenocarcinoma of the Pancreas
Stage IA Pancreatic Cancer
Stage IB Pancreatic Cancer
Stage IIA Pancreatic Cancer
Stage IIB Pancreatic Cancer

Interventions: Drug: gemcitabine hydrochloride
Drug: docetaxel
Drug: capecitabine
Radiation: intensity-modulated radiation therapy
Drug: oxaliplatin
Procedure: pancreatic surgical procedure
Procedure: therapeutic conventional surgery
Other: laboratory biomarker analysis

First Posted Date: 2008-02-07

Last Posted Date: 2017-07-13

Lead Sponsor: University of Washington

Target Recruit Count: 35

Registration Number: NCT00609336

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Computer Assisted Relaxation Learning for Dental Offices

Not Applicable

Completed

Conditions: Dental Anxiety

Interventions: Behavioral: Computer Assisted Relaxation Learning
Behavioral: Pamphlet

First Posted Date: 2008-02-07

Last Posted Date: 2013-02-20

Lead Sponsor: University of Washington

Target Recruit Count: 84

Registration Number: NCT00609648

Locations: 🇺🇸
Dr. Gary Templeman, DDS, Corvallis, Oregon, United States
🇺🇸
Michael C Hazel, DMD, PC, West Linn, Oregon, United States
🇺🇸
Northwest Dental Fears Research, Bremerton, Washington, United States

and more 2 locations

A Single-Blind Placebo Run-in Study of Duloxetine for Activity-Limiting Osteoarthritis Pain

Phase 4

Completed

Conditions: Osteoarthritis
Pain

Interventions: Drug: duloxetine

First Posted Date: 2008-02-07

Last Posted Date: 2008-02-07

Lead Sponsor: University of Washington

Target Recruit Count: 25

Registration Number: NCT00609557

Disseminating Organizational SBI Services at Trauma Centers

Not Applicable

Completed

Conditions: Alcohol Dependence
Alcohol Abuse

Interventions: Behavioral: Brief Intervention

First Posted Date: 2008-02-06

Last Posted Date: 2018-03-07

Lead Sponsor: University of Washington

Target Recruit Count: 878

Registration Number: NCT00607620

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell Lymphoma

Phase 1

Completed

Conditions: Recurrent Adult Diffuse Large Cell Lymphoma
Recurrent Adult Diffuse Mixed Cell Lymphoma
Recurrent Adult Diffuse Small Cleaved Cell Lymphoma
Recurrent Adult Grade III Lymphomatoid Granulomatosis
Recurrent Adult Hodgkin Lymphoma
Recurrent Adult Immunoblastic Large Cell Lymphoma
Recurrent Adult Lymphoblastic Lymphoma
Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma
Recurrent Grade 1 Follicular Lymphoma
Recurrent Grade 2 Follicular Lymphoma

Interventions: Drug: vorinostat
Biological: rituximab
Drug: ifosfamide
Drug: carboplatin
Drug: etoposide
Other: pharmacological study
Other: laboratory biomarker analysis
Genetic: gene expression analysis

First Posted Date: 2008-01-28

Last Posted Date: 2017-05-25

Lead Sponsor: University of Washington

Target Recruit Count: 29

Registration Number: NCT00601718

Locations: 🇺🇸
Puget Sound Oncology Consortium, Seattle, Washington, United States

ACY-7 Oral Administration of Acyline

Phase 1

Completed

Conditions: Healthy

First Posted Date: 2008-01-28

Last Posted Date: 2011-06-09

Lead Sponsor: University of Washington

Target Recruit Count: 4

Registration Number: NCT00603187

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Clofarabine, Cytarabine, and G-CSF in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase 1

Completed

Conditions: Acute Myeloid Leukemia
Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
Adult Acute Promyelocytic Leukemia (M3)
Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)
Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)
Recurrent Adult Acute Myeloid Leukemia

Interventions: Drug: clofarabine
Drug: cytarabine
Biological: filgrastim

First Posted Date: 2008-01-28

Last Posted Date: 2018-03-09

Lead Sponsor: University of Washington

Target Recruit Count: 50

Registration Number: NCT00602225

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Project to Improve Symptoms and Mood in People With Spinal Cord Injury

Phase 4

Completed

Conditions: Spinal Cord Injuries
Major Depressive Disorder
Dysthymia

Interventions: Drug: venlafaxine XR
Drug: placebo

First Posted Date: 2008-01-14

Last Posted Date: 2015-01-01

Lead Sponsor: University of Washington

Target Recruit Count: 133

Registration Number: NCT00592384

Locations: 🇺🇸
University of Miami, Miami, Florida, United States
🇺🇸
University of Alabama, Birmingham, Alabama, United States
🇺🇸
Rehabilitation Institute of Chicago, Chicago, Illinois, United States

and more 3 locations

Interpersonal and Social Rhythm Therapy for Adolescents With Bipolar Disorder

Not Applicable

Completed

Conditions: Bipolar Disorder

Interventions: Behavioral: Treatment As Usual (TAU)
Behavioral: Interpersonal and Social Rhythm Therapy for Adolescents (IPSRT-A)

First Posted Date: 2007-12-19

Last Posted Date: 2012-06-20

Lead Sponsor: University of Washington

Target Recruit Count: 36

Registration Number: NCT00576355

Locations: 🇺🇸
Seattle Children's Hospital, Seattle, Washington, United States

Stimulant Abuser Groups to Engage in 12-Step

Phase 3

Completed

Conditions: Drug Abuse

Interventions: Behavioral: STAGE-12
Behavioral: Treatment as Usual

First Posted Date: 2007-12-14

Last Posted Date: 2016-12-05

Lead Sponsor: University of Washington

Target Recruit Count: 471

Registration Number: NCT00573183

Locations: 🇺🇸
Gateway Community Services, Jacksonville, Florida, United States
🇺🇸
ChangePoint, Inc., Portland, Oregon, United States
🇺🇸
Recovery Centers of King County, Seattle, Washington, United States

and more 7 locations

Home Terms & Conditions Privacy Policy